Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Sherman

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer|June 29, 1999
Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from diseaseC D Sturgis, N P Caraway, D A Johnston, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxineS I Sherman, M D Ringel, M J Smith, et al.
Surgery|December 17, 1998
Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomasJ E Lee, D B Evans, R C Hickey, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 30, 2017
No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancerS I Sherman, R T Kloos, R M Tuttle, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancerS Leboulleux, P R Schroeder, N L Busaidy, et al.
Annals of Surgery|November 24, 1999
Surgical strategy for the treatment of medullary thyroid carcinomaJ B Fleming, J E Lee, M Bouvet, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 1998
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative RegistryD S Cooper, B Specker, M Ho, et al.
Cancer|September 10, 1998
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry GroupS I Sherman, J D Brierley, M Sperling, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinomaE L Mazzaferri, R J Robbins, C A Spencer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2012
The impact of age and gender on papillary thyroid cancer survivalJ Jonklaas, G Nogueras-Gonzalez, M Munsell, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer|June 29, 1999
Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from diseaseC D Sturgis, N P Caraway, D A Johnston, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxineS I Sherman, M D Ringel, M J Smith, et al.
Surgery|December 17, 1998
Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomasJ E Lee, D B Evans, R C Hickey, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 30, 2017
No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancerS I Sherman, R T Kloos, R M Tuttle, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancerS Leboulleux, P R Schroeder, N L Busaidy, et al.
Annals of Surgery|November 24, 1999
Surgical strategy for the treatment of medullary thyroid carcinomaJ B Fleming, J E Lee, M Bouvet, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 1998
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative RegistryD S Cooper, B Specker, M Ho, et al.
Cancer|September 10, 1998
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry GroupS I Sherman, J D Brierley, M Sperling, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinomaE L Mazzaferri, R J Robbins, C A Spencer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2012
The impact of age and gender on papillary thyroid cancer survivalJ Jonklaas, G Nogueras-Gonzalez, M Munsell, et al.
Pageof 4